Prophylaxis and Antibiotic Therapy in Management Protocols of Patients Treated with Oral and Intravenous Bisphosphonates

Overview

Journal J Clin Exp Dent

Specialty Dentistry

Date 2017 Feb 3

PMID 28149479

Citations 20

Authors

Elena-Beatriz Bermudez-Bejarano

Maria-Angeles Serrera-Figallo

Aida Gutierrez-Corrales

Manuel-Maria Romero-Ruiz

Raquel Castillo-de-Oyague

Jose-Luis Gutierrez-Perez

Daniel Torres-Lagares

Affiliations

Soon will be listed here.

Abstract

Introduction: Osteonecrosis of the jaw (MRONJ) linked to bisphosphonate treatment has specific characteristics that render its therapeutic management challenging for clinicians. Poor response to standard treatment makes it essential to take special precautions when treating this type of disease; therefore, antibiotic prophylaxis and/or antibiotic therapy have been proposed as effective and helpful tools in these situations.

Objectives: This article seeks to assess published evidence in order to evaluate the different protocols used for antibiotic prophylaxis and/or antibiotic therapy in the general context of patients treated with bisphosphonates.

Material And Methods: A literature review of the last 10 years was carried out in PubMed using the following keywords: "antibiotic prophylaxis and osteonecrosis," "bisphosphonates AND osteonecrosis AND dental management," "bisphosphonate AND osteonecrosis AND antibiotic prophylaxis AND oral surgery." A total of 188 articles were obtained, of which 18 were ultimately selected.

Results And Discussion: In patients treated with oral and intravenous bisphosphonates without chemotherapy-associated osteonecrosis of the jaw, antibiotic prophylaxis prior to oral surgery is an important tool to avoid osteonecrosis and promote healing of the affected area. If the patient previously exhibited chemotherapy-associated osteonecrosis after tooth extraction, antibiotic prophylaxis is indicated to prevent recurrent osteonecrosis and promote healing of the extraction site. If chemotherapy-associated osteonecrosis is already present, antibiotic therapy is a vital part of conservative management to reduce the symptomatology of MRONJ and keep it from worsening. Finally, a lack of clinical data and randomized controlled trials makes it difficult to choose the most appropriate protocol for the various clinical situations studied. Bisphosphonates, antibiotic prophylaxis, maxillary osteonecrosis, antibiotic treatment.

Citing Articles

Prevention of bisphosphonate-related osteonecrosis of the jaw with basic fibroblast growth factor: an experimental study in rats.

Kurokawa S, Yagyuu T, Funayama N, Imada M, Kirita T Odontology. 2025; .

PMID: 39979497 DOI: 10.1007/s10266-025-01073-w.

[Osteoporosis-Definition, risk assessment, diagnosis, prevention and treatment (update 2024) : Guidelines of the Austrian Society for Bone and Mineral Research].

Dimai H, Muschitz C, Amrein K, Bauer R, Cejka D, Gasser R Wien Klin Wochenschr. 2024; 136(Suppl 16):599-668.

PMID: 39356323 PMC: 11447007. DOI: 10.1007/s00508-024-02441-2.

A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials.

Hanna R, Miron I, Dalvi S, Arany P, Bensadoun R, Benedicenti S Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204116 PMC: 11357434. DOI: 10.3390/ph17081011.

Reduction of MRONJ risk after exodontia by virtue of ozone infiltration: A randomized clinical trial.

Di Fede O, La Mantia G, Del Gaizo C, Mauceri R, Matranga D, Campisi G Oral Dis. 2024; 30(8):5183-5194.

PMID: 38807567 PMC: 11610715. DOI: 10.1111/odi.15006.

Jiang A, Zhang Z, Qiu X, Guo Q Arch Toxicol. 2023; 98(3):689-708.

PMID: 38155341 DOI: 10.1007/s00204-023-03653-7.

References

Eckardt A, Lemound J, Lindhorst D, Rana M, Gellrich N . Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem. Anticancer Res. 2011; 31(6):2313-8. View

Ruggiero S, Mehrotra B, Rosenberg T, Engroff S . Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004; 62(5):527-34. DOI: 10.1016/j.joms.2004.02.004. View

Van den Wyngaert T, Claeys T, Huizing M, Vermorken J, Fossion E . Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol. 2008; 20(2):331-6. DOI: 10.1093/annonc/mdn630. View

Leizaola-Cardesa I, Aguilar-Salvatierra A, Gonzalez-Jaranay M, Moreu G, Sala-Romero M, Gomez-Moreno G . Bisphosphonates, vitamin D, parathyroid hormone, and osteonecrosis of the jaw. Could there be a missing link?. Med Oral Patol Oral Cir Bucal. 2016; 21(2):e236-40. PMC: 4788805. DOI: 10.4317/medoral.20927. View

Carmona I, Diz Dios P, Scully C . An update on the controversies in bacterial endocarditis of oral origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93(6):660-70. DOI: 10.1067/moe.2002.122338. View

Vescovi P, Giovannacci I, Merigo E, Meleti M, Manfredi M, Fornaini C . Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by low-level laser therapy. J Craniofac Surg. 2015; 26(3):696-9. DOI: 10.1097/SCS.0000000000001665. View

Ferlito S, Puzzo S, Palermo F, Verzi P . Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases. Br J Oral Maxillofac Surg. 2011; 50(5):425-9. DOI: 10.1016/j.bjoms.2011.08.004. View

Ponte Fernandez N, Estefania Fresco R, Urizar J . Bisphosphonates and oral pathology I. General and preventive aspects. Med Oral Patol Oral Cir Bucal. 2006; 11(5):E396-400. View

Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G . Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg. 2010; 68(4):797-804. DOI: 10.1016/j.joms.2009.10.026. View

10.

Gutierrez J, Bagan J, Bascones A, Llamas R, Llena J, Morales A . Consensus document on the use of antibiotic prophylaxis in dental surgery and procedures. Med Oral Patol Oral Cir Bucal. 2006; 11(2):E188-205. View

11.

Eckert A, Maurer P, Meyer L, Kriwalsky M, Rohrberg R, Schneider D . Bisphosphonate-related jaw necrosis--severe complication in maxillofacial surgery. Cancer Treat Rev. 2006; 33(1):58-63. DOI: 10.1016/j.ctrv.2006.09.003. View

12.

. Prescribing antibiotics in odontology and stomatology. Recommendations by the French Health Products Safety Agency. Fundam Clin Pharmacol. 2004; 17(6):725-9. DOI: 10.1046/j.0767-3981.2003.00205.x. View

13.

Epstein M, Wicknick F, Epstein J, Berenson J, Gorsky M . Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110(5):593-6. DOI: 10.1016/j.tripleo.2010.05.067. View

14.

Vescovi P, Merigo E, Meleti M, Manfredi M, Guidotti R, Nammour S . Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med. 2011; 41(3):214-21. DOI: 10.1111/j.1600-0714.2011.01091.x. View

15.

Hoefert S, Eufinger H . Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2010; 69(2):362-80. DOI: 10.1016/j.joms.2010.06.200. View

16.

Marx R . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003; 61(9):1115-7. DOI: 10.1016/s0278-2391(03)00720-1. View

17.

Alons K, Kuijpers S, de Jong E, van Merkesteyn J . Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 107(2):e1-7. DOI: 10.1016/j.tripleo.2008.09.021. View

18.

Marx R, Sawatari Y, Fortin M, Broumand V . Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005; 63(11):1567-75. DOI: 10.1016/j.joms.2005.07.010. View

19.

Stanton D, Balasanian E . Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases. J Oral Maxillofac Surg. 2009; 67(5):943-50. DOI: 10.1016/j.joms.2008.12.057. View

20.

Shrout M, Scarbrough F, Powell B . Dental care and the prosthetic joint patient: a survey of orthopedic surgeons and general dentists. J Am Dent Assoc. 1994; 125(4):429-36. DOI: 10.14219/jada.archive.1994.0047. View